Argan INC Form 4 insider transactions

Former ARGAN CFO Richard H. Deily filed a Form 4 indicating he is no longer subject to Section 16, while disclosing his beneficial ownership of common stock and various derivative securities.

ARGAN Inc.'s CEO, Charles Edwin Collins IV, reported exercising stock options and subsequently selling a portion of his common stock holdings for significant gains under a pre-planned trading arrangement.

Argan Inc. Director William F. Griffin Jr. transferred 80,000 common shares between two trusts on August 5, 2025.

Argan Inc.'s Chief Executive Officer of Gemma, Charles Edwin Collins IV, sold a total of 6,500 shares of common stock in two separate open market transactions.

ARGAN Inc.'s Compliance Officer and former CFO, Richard H. Deily, executed a profitable transaction involving the exercise of stock options and subsequent sale of common stock.

ARGAN Director Jeffrey John Ronald Jr. sold 2,621 shares of the company's common stock on the open market for an average price of $235.63 per share.

A charitable trust associated with ARGAN Director Cynthia Flanders sold 2,000 shares of the company's common stock on the open market for $234.56 per share.

ARGAN Inc. Director Peter W. Getsinger reported the sale of 3,456 common shares and the gifting of 1,999 common shares, reducing his beneficial ownership to 12,896 shares.

ARGAN Inc. Director William F. Leimkuhler reported the sale of 11,655 shares of common stock across two open market transactions in late June 2025.

ARGAN Inc. Director Peter W. Getsinger exercised stock options to acquire 6,465 shares of common stock at $71.75 per share, increasing his direct beneficial ownership to 18,351 shares.

ARGAN Inc. Director Peter W. Getsinger was granted 530 time-based restricted stock units (TRSUs) on June 17, 2025, which are set to vest fully on April 17, 2026.

ARGAN Inc. Director Cynthia Flanders was granted 530 time-based restricted stock units, vesting fully on June 17, 2026, as disclosed in a recent SEC Form 4 filing.

ARGAN Inc. Director William F. Leimkuhler was granted 530 time-based restricted stock units on June 17, 2025, which are set to vest fully on April 17, 2026.

ARGAN Inc. Director Karen Sweeney reported the vesting of previously granted restricted stock units into common stock and the grant of new restricted stock units, as disclosed in a recent SEC Form 4 filing.

ARGAN Inc. Director James W. Quinn was granted 530 time-based restricted stock units, which are set to vest fully on April 17, 2026.

ARGAN Inc. Director Jeffrey John Ronald Jr. was granted 530 time-based restricted stock units, which are set to vest fully in April 2026.

ARGAN Inc. Director Lisa Larroque was granted 530 time-based restricted stock units, which are set to vest fully by April 17, 2026.

Cynthia Flanders, a Director at ARGAN Inc. (AGX), reported the sale of 15,000 shares of common stock for approximately $3.3 million, reducing her direct beneficial ownership.

ARGAN Inc. Director Peter W. Getsinger has reported the vesting of 388 time-based restricted stock units, resulting in the acquisition of 390 shares of common stock.

ARGAN Inc. Director Karen Sweeney has increased her direct ownership in the company by acquiring 390 shares of common stock through the vesting of previously awarded restricted stock units.

Argan Inc. Director Rainer H. Bosselmann exercised stock options and subsequently sold a significant number of common shares in open market transactions, reducing his direct beneficial ownership.

Argan Inc. Director James W. Quinn engaged in substantial insider trading activity, exercising a large number of stock options and subsequently selling 40,000 shares of common stock on the open market.

ARGAN Inc.'s President and CEO, David Hibbert Watson, executed a series of pre-planned transactions, exercising stock options and subsequently selling 20,000 shares of common stock for over $4.2 million.

ARGAN Inc. Director Cynthia Flanders reported the exercise of multiple stock options and the vesting of restricted stock units, significantly increasing her direct beneficial ownership of common stock.

ARGAN Inc.'s Chief Executive Officer, Charles Edwin Collins IV, exercised stock options and simultaneously sold 1,265 shares of common stock on June 9, 2025, realizing a significant gain.

Argan Inc. Director John R. Jeffrey Jr. reported the sale of 5,500 shares of common stock for over $1.1 million and the acquisition of 390 shares through the vesting of restricted stock units.

ARGAN Inc. Director William F. Leimkuhler recently exercised multiple stock options and vested restricted stock units, subsequently selling a portion of his acquired common stock.

William F. Griffin Jr., a director at Argan Inc., filed a Form 4 detailing transactions involving common stock and Time-Based Restricted Stock Units.

Director Alexander Lisa Larroque reports the grant of 695 Time-Based Restricted Stock Units (TRSUs) of Argan Inc. common stock on April 16, 2025, vesting fully on April 16, 2026.

Joshua Baugher, CFO of Argan Inc., reports the vesting of restricted stock units and grants of new stock options and performance-based units.